UNSPSC 41181557: Retinol-binding protein immunological test system

In this classification, a Retinol-binding protein immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Retinol-binding protein. US FDA regulates Retinol-binding protein immunological test system under 21 CFR 866.5765 and under FDA product code CZS.

UNSPSC 41181557 Retinol-binding protein immunological test system (Commodity) shows minimal alignment between the code's nominal scope and actual state and local procurement activity. The recent opportunities block contains no solicitations for retinol-binding protein testing systems or related immunological assays; instead, the tagged opportunities span laboratory equipment repair and maintenance, general laboratory testing services, spectrophotometer replacement, oil analysis for electrical utilities, materials testing for construction, LIMS procurement, meter test boards, water well construction, fatigue testing systems, and lock-in amplifiers. The code appears to be a narrow diagnostic or clinical chemistry test methodology that does not map to current state and local buying patterns in the source.

The geographic range of activity in the block spans Florida, Texas, Oregon, Connecticut, and California, though the opportunities themselves do not reflect procurement under the retinol-binding protein code. Marion County, Oregon; the Texas Department of State Health Services; the City of Tampa; Lubbock Power & Light; Harris County Toll Road Authority; the City of Orlando; Broward County Transportation Department; the Town of Waterford, Connecticut; the County of Santa Clara; the City of Ocala; the City of Palm Bay; and Lamar University appear as issuing bodies, but none are soliciting immunological test systems or related clinical laboratory commodities. Without recent opportunities that genuinely correspond to the code's scope, this classification appears inactive or misapplied in current state and local procurement practice.